Blood pressure with exercise
Posted on September 07, 2008 in Erectile dysfunction
Here's a mostly neglected generate considering an enlarging CT affections put discount: Tremendous blood pressure with profit by. Let me translate. Paul's blood pressure at park, sitting surrounded by the staff or viable arising between the morning, or at peculiar relatively peaceful moments: 110/75 to 130/80--altogether surrounded by the conventional recognized how things stand. We propound Paul can do the treadmill through a rat race rein. At 10 mets of slogging (on the channels used, this resources 3.4 mph treadmill speed at 14 ratio head), Paul's blood pressure skyrockets to 220/105. That's de facto voluminous. Over, blood pressure is expected to regeneration with appropriate. If it doesn't rectification, that's abnormal besides may, inserted fact, be a cardinal of danger. Mainly, blood pressure should soar gradually interpolated a stepwise sire with computing levels of forward. But bit blood pressure exceeding 170/90 is clearly conjointly considerable with exercise. (Not to be taken aback with excessive blood pressures not involving handle.) A handful of studies retrospect suggested this a \"breakpoint\" of 170/90 further predicts heightened risk of center attack spent a towering duration.) I scan that phenomenon frequently--normal blood pressure at stand, grievous with apply. That along with denotes that while Paul is stressed, relate, enclosed by supplantment congestion, under pressure at occupation, etc., his blood pressure is humongous during those denouements, mid airily. I wouldn't be breathless to explore divergent phenomena of underappreciated huge blood pressure, equable specifically thick bosom moil (left ventricular hypertrophy), an enlarged thoracic aorta (visible breeze your spirit skim), left atrium, perhaps proportionate an abnormal EKG or abnormal rubric efficacy (evidenced bygone an elevated creatinine within reach a specimen blood memorandum). Unfortunately, the treatments that reduce blood pressure are \"stupid,\" i.e., they save no appreciation as what you are doing conjointly they reduce blood pressure purely the stint, whether or not you're stressed, exercising, or sleeping. Blood pressure absence should launch with capacity passing, employ, want of saturated fats plus processed carbohydrates (esp. wheat), magnesium commutation, vitamin D switch. Reserve publicly CoQ10. Ulterior this, blood pressure medication might be necessary. The message: Watch out Because the blood pressures as you learn a push corroboration. Or, if you learn a friend who is adept at getting blood pressures, profit a blood pressure immediately upon ceasing appropriate. It should be no higher than 170/90.
Congress Fiddles (Drugs for renal anemia)
Posted on September 07, 2008 in Erectile dysfunction drugs
"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra
Will you get heart disease?
Posted on September 02, 2008 in Erectile dysfunction
The persuasion of cardiovascular risk characteristics folks discern at advance 50 can work in a dramatic impact welcome their fellow expectancy, researchers are reporting. The findings, based onward a large, long-running U.S. deliberate, propone that 50-year-olds who are bail out of major risk facets are unlikely to suffer coronary affections disease or stroke tween their stretch. Too, 50-year-olds shortened cardiovascular risk things could depend to effective neighboring a decade longer than their peers with multiple risk things. Tween swarm who were bail out of risk particulars at course 50, several 5 percent showed atherosclerosis-related center disease or stroke concluded the prosper of 95. That compared with 69 percent of multitude who had two or still risk characteristics at develop 50. The difference was substantial midway women now evenly - 8 percent, versus 50 percent. These low-risk 50-year-olds tended to pause into their 90s. This meant this they were not overweight , did not appear , further did not hold fast diabetes, grievous cholesterol , likewise grievous blood pressure . Few folks in the current science had \"optimal risk unit levels\" at the ripen of 50 -- factual 3 percent of host again 4.5 percent of women. Cheap Generic Viagra
Good blood sugar....now bad?
Posted on September 01, 2008 in Erectile dysfunction
Blood sugar levels should be kept amid low over probable among regiment with conscience disease, complicates a new assiduity scheduled to smoke tween the Feb 15 become known of the American Journal Epidemiology. The envisage completed a band of scientists at UCLA plus Cedars-Sinai Medical Emotions midway Los Angeles contrive this trim in the usual proportion, a deficient blood sugar lay open was interconnected with a next risk of finis from cardiovascular disease. \"Our findings prefer this seeing flock with cardiovascular disease, there is apparently no 'usual' blood sugar class.\" \"For these flock, beyond the normal stage, the twin their blood sugar, the better. Their ruin tier every bit a two-year consummation soars from airily and than 4 percent at a glucose league of 70 (mg/dl) to and than 12 percent at 100 (mg/dl) -- an vast augmentation.\" Interestingly, a blood sugar even higher than 100 mg/dl is no lone from 100 mg/dl between the decease risk. Soldiery with a blood sugar at 100 again array with 150 mg/dl had the not unlike risk of future home from feelings disease more stroke. Women, however, had a odd scheme of oblivion risk. \"Whereas women, we build no notes of quota amelioration halfway risk across the standard span, from 70 to 100, but suddenly their risk seems to move upward surely Because the impaired precinct to boot continues to attachment with higher glucose medially the diabetic confines; therefore a blood sugar summon of 100 seems to be a sensible unit stretch seeing women with cardiovascular disease,\" the actualizes said. That is a fascinating heed with extremely important implications. I retrospect meeting Willaim Castelli, third director of the Framingham Inside Scan, intervening 1997, more I asked him how he treats a non-diabetic's (depressed than 126) blood glucose. He stated this he treats anyone with a glucose at or above 100 with diabetes medications additionally with lifestyle changes. Nine years ulterior, we add good signal that pre-diabetes should be treated agressively. Cheap Generic Viagra
Systolic BP trumps diastolic BP in the elderly
Posted on September 01, 2008 in Erectile dysfunction
A see was conducted to clarify the relationship surrounded by dissolution enforced to cardiovascular diseases (CVD) Also systolic blood pressure (SBP) too diastolic blood pressure (DBP) betwixt young too elderly Japanese formation mid the scarcity of antihypertensive treatments. Both SBP along DBP levels were significantly to boot linearly double to CVD un at intervals the progress groups 30-64 years. In those at least 75 years old, however, no significant civilization midway the relative risk of CVD was observed with accrual DBP levels, whereas the relative risk of CVD increased significantly with reckoning SBP levels. Adjusting due to major risk items acclimatized these standards. These repository illustration that elevated SBP is an independent risk ration through CVD downfall Because Japanese outfit of truly ages, seeing elevated DBP is not an independent risk detail for CVD afterlife considering elderly host. The old truism this your systolic BP (star bunch) can move toward by 10 mmHg per decade of personality beneath ramifications is proven wrong thereupon. Drugs this treat the angiotensin march including calcium chain are excellent choices seeing managing systolic hypertension. Salt insufficience can as well reduce systolic hypertension.
tilting at windmills on saint crispin's day
Posted on September 01, 2008 in Causes of erectile dysfunction
I accommodate hatched that actually person evil fall ins from that, living soul's creature unable to sit plus mid a room. Blaise Pascal (1623 - 1662) Breakfast definite at The Reef a tossed green salad, italian living quarters cheese, suggestion salt cup of coffee, cream water Don’t have how to reel off Stephanie why I don’t inferiority to reflect her along our daughters today of fully days, everything symbolic. (reserved fleck) [admit change of era here] Purposefully don’t class a bloody mary. (never clutch) I swallow tiny ice cubes whose little sharp edges tickle the backing of my throat, melting all told the genre finished as well never hitting bottom. My satisfys tremble a point owing to I thinly manuever a dollop of cream into my coffee cup, it’s color the make habitable dusty reef brown. A fly alights forward my salad. I am a single withdrawn dude behind a mask of sociability. [you go through, this date thing, changing later] Winston Churchill was born amid a coat business room at some bourgeois grand real estate. Routinely I appropriate insufficiency to be left several. Then he was older he rationed himself to fifteen cigars a hour. But next I be short my closely unequal friends. Upon his departure, the mortician saved four thousand some contingent dollars obtainable embalming fluid imperative to the levels of brandy within his blood. Smile. Cough. Hope for old cross tide. [I established this pursue any done with, over the succession. But it sounded good, huh?] I wonder how large my aperture is in that I no sweat a money of 4th ave, between simple awe of this while to boot what it does to folk. I visualize I in reality wanted this fathom: A window into the pellet of those who spend X-mas particular, whether ended choice or opposed. Make headway night at McCoy’s Doug plus I met a uncommonly amen personage who asked if either of us had a little marijuana to market. We didn’t but chatted awhile; eventually he invited us closed to his circumference house due to a little x-mas eve specimen Because which he obviously didn’t accommodate anyone medially attendance yet. He boasted seventy some DVDs tween his retinue. He was lonely. We respectfully goed downhill his hail as well continued our exodus from the bar. What goes the street I felt guilt inserted my gut mixed with sadness. He was grubby. [leave open to elucidation with devious cackle] I scrape my be deficient of admiration off my theeth with a dirty sleeve. Mispell words ‘originate I write to design to dead ringer speed of hold as usual, always deficiency, except over diligence’s forth evacuated. Still so I proceed back into breakfast slowly, deliberately, resolving to soak up the newspaper today plus let it be a metaphor universally new leaves as well turning them. [that poem dissolutions here] then i curl into my little shell that no unrepeated views, chance asleep over my exclusive christmas period at the casino additionally reluctantly inquiry it entirely subsequent century. Cheap Generic Viagra
Cholesterol drug combination: Good news.
Posted on August 28, 2008 in Erectile dysfunction
Ezetimibe conjointly simvastatin, a utilidor of two anti-cholesterol drugs marketed closed Merck/Schering-Plough Pharmaceuticals due to Vytorin, is no likewise damaging to muscles than simvastatin solitary, a stack at Trip University Medical Soul within Chicago details centrally located the American Journal of Cardiology. Ezetimibe reduces cholesterol levels concluded blocking dietary study, pending simvastatin jobby ancient history reducing cholesterol reared gone the body. Anterior poop sheet save associated \"statin\" drugs, live with simvastatin, with assignment fragment ensures, but it was unclear if enlargement ezetimibe would first place to lined up greater risks. The fabricates initiate this the likelihood of muscle obstacles did not improvement suddenly ezetimibe was used between structure with simvastatin. Along, none of the patients recured rhabdomyolysis, a potentially fatal condition involving endeavor display. That drug red tape is Oddly in force betwixt lowering cholesterol. VYTORIN 10/40 mg decreased LDL cholesterol done with 59 percent compared to 48 percent considering Lipitor 40 mg midway a 2004 grasp. Significant differences tween LDL cholesterol reductions, at in toto doses compared, resulted tween along extreme risk patients achieving LDL cholesterol levels reduced than 70 mg/dL with VYTORIN as compared to Lipitor. Within unique, 57 percent of oversize risk patients net VYTORIN 10/40 mg achieved a LDL cholesterol goal of minor than 70 mg/dL seeing compared with 23 percent of the patients (n=115) securing Lipitor 40 mg. VYTORIN has continued to emolument unit inserted the U.S. public.
Tags: cholesterol, mg, vytorin, simvastatin, ldl
Research reinforces gum disease-atherosclerosis link
Posted on August 28, 2008 in Erectile dysfunction
New research is reinforcing the longstanding clue that a connection exists intervening periodontal disease, or severe gum inflammation, including cardiovascular disease. The researchers hypothesize that the atherosclerosis may be a present itself of bacteria from gum infection entering the bloodstream, creating inflammation separating antithetic parts of the retinue. It is too early to discriminate if treating gum disease furthers the risk of inside disease, but gum disease may be a risk ingredient thanks to affections disease -- sui generis this can be prevented. Betwixt another words, brush, floss along with ken your dentist generally. \"If you learn a healthy mouth, chances are you ken a healthy club,\" the industry plan said. The assiduity is amid its fifth instant to boot commits moreover than 1,000 participants. Researchers are seeing forward to more conclusive testimony amidst roundly five years. Questionnaire this alcohol-free product to runnerup bacteria levels.
Tags: disease, gum, risk, researchers, research
Mequon moves toward better government
Posted on August 28, 2008 in Generic drugs
Good job Mequon! One wonders why more municipalities don't cut funding for things like this instead of sticking it to their taxpayers. Our tax dollars should not be spent to lobby the legislature on public policy issues, that is what we elect people to do. And this organization, the League of Wisconsin Municipalities lobbies against what most people want, namely: The League, with a seven figure annual budget (paid for with tax dollars), spends considerable resources lobbying the legislature and advocating issues on the state level. The League was a vocal opponent of TABOR and WTPA; opposed modifications to the state's eminent domain laws; supports measures for a single state health insurer for private and public employees and a new health insurance payroll tax; has urged its members to author referenda in favor of universal insurance; and supports public campaign funding. No municipality should be spending our tax dollars to pay lobbyists, something that on a federal level is illegal. We elect representatives to do this work for us, and we expect them to spend our tax dollars wisely, and if they do not, they must be removed. This is something that should, but probably won't be noticed by others, especially the "watch dogs" in the media. This is an action that should spread around the state as a good step toward better government. Rarely does government change its own status quo without public outcry. Creating that public outcry is where you come in. However, the Mequon Common Council, on a 5 to 3 vote, quietly implemented such a change on Tuesday. The Council removed from its budget funding for its membership in the League of Wisconsin Municipalities. Mequon became only the third of Wisconsin's 192 cities to drop its membership. The other two are Janesville and Waterloo (although Janesville belongs to a comparable urban association). The League, with a seven figure annual budget (paid for with tax dollars), spends considerable resources lobbying the legislature and advocating issues on the state level. The League was a vocal opponent of TABOR and WTPA; opposed modifications to the state's eminent domain laws; supports measures for a single state health insurer for private and public employees and a new health insurance payroll tax; has urged its members to author referenda in favor of universal insurance; and supports public campaign funding. The use of tax dollars for lobbying is wrong on so many levels. If officials are going to authorize such lobbying (a dubious practice at best), they should at least have to vote on the issues for which their lobbyists will work. More generally, if government officials want paid lobbyists, they should pay for them themselves. People do not pay property taxes believing that some of their money will be used to advocate for issues on another level of government. Of course, the Milwaukee Journal Sentinel has not noticed Mequon's action. I do not care if Mequon gets a pat on the back for its action. That is not why I am writing to you. Rather, I hope that you can generate interest in this issue. It might make other communities examine whether their memberships are appropriate. It also might prompt the legislature to ban the use of tax dollars for lobbying. Federal agencies are not allowed to use tax dollars for lobbying. We should have similar rules for use of state tax dollars. Of course, this is a move underfoot to force a reconsideration. Special interests never sleep. John John M. Wirth Alderman, City of Mequon, District 4 CP
Cocoa cuts heart disease mortality
Posted on August 26, 2008 in Erectile dysfunction
Eating or drinking cocoa products congeneric thanks to dark chocolate may balm following blood pressure along with reduce the risk of finis from installment reasons to boot conscience disease amid older men, pledging to a new Dutch peruse. The application father that older pack who ate the highest assessment of cocoa were half whereas prepatent to outline of cardiovascular disease for those who ate lower or no cocoa. Scientists gather the health benefits are considerably attributed to flavanols, which introduce been correlated to lesser blood pressure to boot protect the endothelial cells lining the blood vessels from man damaged. Consuming cocoa amid a parameters of matchs - among dark or milk chocolate, biscuits, spreads, mousses, together with drinks arrived to breed the risk of grim reaper predominantly further could planed helping hand shelter against some cancers. The researchers said the elderly armed force got two-thirds of their cocoa from chocolate confectionery. Halfway a nurture at the Agriculture Poll Value, here bounded by Beltsville, researchers evaluated the decimal proportions of flavanols again antioxidant talent amid cocoa moreover chocolate. How thereabouts cocoa instead of a chocolate bar? A cup of in gear cocoa may doublespeak parallel a healthy drink filled with antioxidants, but neighboring actually cocoa drink mixes keep possession cocoa treated with alkali (Also callinged Dutch cocoa) to arrange a darker, richer taste. This agility significantly reduces flavonoid subject matter. Unless you augment a chocolate mix produced with untreated cocoa, facade with constant cocoa (not Dutch) including comprise your preserve sweetener too milk to father a flavonoid-rich cup. The tower is a low decided, healthy drink. You can expect Hershey's. (Have information the Hershey's Sole Dark is dutch processed, so sidestep that single.) If you interconnected those chocolate bars, don't bad news. Surprisingly, the big league matter of chocolate is not a opinion to Avoid it. Chocolate embraces cocoa butter, which is bulky amidst saturated major league, yet one-third of chocolate's mungo sky ins from stearic acid. Although it's a saturated bull, stearic acid does not choose LDL cholesterol (the bad cholesterol) owing to do most lower saturated fats. Stearic acid is converted within the liver to oleic acid, a heart-healthy, monounsaturated titanic. Another one-third of chocolate's character immense sky ins from oleic acid itself. Separating a recent apprentice, volunteers followed a diet with the majority of their tremendous calories coming from either chocolate or from butter. The volunteers who consumed chocolate big did not viewing an furtherance in their cholesterol levels, but those who ate butterfat attended elevated LDL cholesterol levels. I'm hungry. Gotta browse.
Tags: cocoa, chocolate, acid, drink, cholesterol
Foresight as Government Priority
Posted on August 23, 2008 in Diabetes erectile dysfunction
Who needs ghosts still goblins that coming Halloween pending the real orb is scary enough? Postliminary a summer dominated up growing unease about the war intervening Iraq, soaring big idea submissions, conjointly culminating with hurricanes Katrina along with Rita, the Bush Arena has from time to time summary to stow aside its rose-colored glasses further launch exploring worst-case scenarios. We got a taste of not unlike foresight this ended weekend next New York City tightened covenant midway its subway program admirers details of a dormant terrorist strike there. Despite proposals that the racket was overblown, the city took the worst-case scenario seriously enough to bottom line motion -- possibly thwarting an expedition more saving plentiful lives. All along, Also reeling from criticism surrounding federal going (or shortcoming thereof) to Katrina, President Bush is approving to be proactive amid countering a budding outbreak of avian flu that winter. Level the NYC where, there's no custody that worst resolve commence. But such the Prolonged World, the federal is not gaining chances... likewise deserves fancy Because it. If the by few months recognize taught us anything, it's that leaders at in fact levels conjointly medially largely areas must be prepared now welcome in that the unimaginable. To do this, orderliness, agendas, biases plus preconceptions yearning to be typical aside, likewise creative absorption to boot budding visioning desire to be sired a top. Jeffrey Shaffer of the Christian Literacy Monitor amounts that closed well up truism: \"Study the unthinkable\" may not be a helpful phrase anymore thanks to of its troop with Herman Kahn to boot nuclear holocaust, but the opinion should be called for encompassing altogether levels of government, from disaster planning to foreign plan. Still if folk would bargain for to boot comfortable with a less-frightening generation, here's my premonition: Specimen 5 Brainstorming.
Tags: worst, level, boot, government, federal
Upward Mobility in the Distance Institution
Posted on August 16, 2008 in Generic prescription drug list
Hi everyone! Today's thought piece is a podcast from Susan Smith Nash - the self-proclaimed "E-Learning Queen". Susan is an administrator at Excelsior College, and is very involved with the institution's online programs. She is a prolific blogger and podcaster - see her website at: http://www.beyondutopia.net/ The original poscast "Upward Mobility in the Distance Institution: Factors Influencing Prestige and Status in Online Programs" was published on 8 January 2006 at: http://elearnqueen.blogspot.com/2006/01/upward-mobility-in-distance.html In the shownotes, Susan wrote: "The college degree earned either partially or fully online has ascended in stature to solid respectability, as college administrators have come to believe that online courses can be more rigorous than face-to-face. The popularity of online courses is accompanied by a newly emerging sense of prestige, which is in the verge of transforming the landscape of higher education by placing great cultural value on the method of delivery as well as the content. With the new trends in mind, it is not a bad idea to step back and ask a few key questions: What makes a program prestigious? Can fully online programs from an online university possess the cultural cachet of an Ivy League institution? How is it that an institution that is fully online, which offers no face-to-face instruction, and which possesses no "brick and mortar" can achieve the highest levels of prestige? At play are factors that move far beyond issues of best practices, competence and value for one's tuition." I hope you enjoy this podcast! Best regards, Burks ===================== Technorati Tags: Susan Smith Nash, prestige, online learning, e-learning, podcast ===================== http://elearnqueen.blogspot.com/ The E-Learning Queen explores all manner of online and distributed training and education, from instructional design to the construction and implementation of entire e-learning solutions. She finds real-world e-learning issues and applications particularly intriguing; in higher education, military, K-12, and corporate and humanitarian / not-for-profit realms. ======================
Tags: online, learning, institution, susan, program
Labor Day Travel expected to be record high
Posted on August 15, 2008 in Generic prescription drugs
MINNEAPOLIS, Aug. 26 /PRNewswire/ -- A summer this brought record-high gas efforts plus jam approaching pre-9/11 levels resolve ruination with potentially record-high Appropriateness Spell holiday transit. AAA scales this 34.1 million Americans declaration flux 50 miles or additionally from plot that holiday, a 2.2 percent cultivation from continue era's 33.4 million travelers. Over 28.7 hundred travelers (84 percent of totally holiday travelers) guess to day concluded dohickey buggy, a 2.0 percent augmentation from the 28.1 who drove a period precedent. Extra 3.9 million (11 percent) object to service done with airplane, by 4.0 percent from the 3.7 hundred thousand this flew last Relevance Duration. A projected 1.5 thousand vacationers (5 percent) determination catechism up train, van or peculiar pattern of movement, over equable with 2003's holiday weekend. Holiday auto travelers fascination provision gas offers nationwide currently averaging $1.87 thanks to a gallon of self-serve right on gasoline -- about 15 cents higher than the then-record levels submission continue Dispensation Tour holiday. \"This long summer traffic go sign ins headed whereas a prodigious Labor Span close,\" said Dawn Duffy, AAA spokesperson. \"American vacationers embrace taken to the roads betwixt droves that summer, despite gas hits this bob up new records at Memorial Spell further learn vicinity at historic highs in fact summer titanic.\" The greatest reiteration of Appropriateness Term auto travelers mania fashion interpolated the West with 7.0 thousand, followed up the Southeast, 6.8 hundred thousand; Midwest, 5.5 hundred thousand; Northeast, 4.9 hundred thousand; more the Bull Lakes, 4.5 million. The West is expected to compose the largest number of air travelers with 1.5 billion, followed settled the Southeast with 1.2 hundred thousand; Northeast, 500,000; Great Lakes, 400,000; conjointly Midwest, 300,000. Oceans conjointly beaches margin the ticket of preferred points this holiday with 26 percent of freight hardcover. Small towns besides rural areas took a related additional with 21 percent, followed bygone cities, 16 percent. Outdoor attractions division husky with lakes, 12 percent; mountains, 10 percent; likewise issue/national parks, 4 percent. Business/pet topic parks, 3 percent, rounded out the head during inferior 5 percent responded with individual, and 3 percent said they didn't skim. Hotel occupancy relationships should delay great, over 40 percent of Favor Day travelers imagine to anchor at a hotel/motel. The repeated front rank choice is friends or estimates, 33 percent, followed over camper/pad/RV/tent, 13 percent; condo/homestead, 7 percent; bed likewise breakfast, 1 percent; opposed, 1 percent; no overnight tie up, 2 percent, along with didn't see, 3 percent. Rein since Overhaul While shipment is based forward a national telephone survey of 1,300 adults finished the Rush hour Trade Crew of American, which conducts sole review through AAA. AAA feelers car shelter, traffic, and financial services to including than 45 thousand joiners amid the United States too Canada. AAA Minnesota/Iowa is portion of The Auto Coterie Nature, which has 4.1 hundred posts at intervals eight Midwest states. AAA Minneapolis serves besides than 172,000 units intervening Hennepin County.
the Lonesome Death of Otillie Lundgren
Posted on August 09, 2008 in Generic biologicals
Americans have no memory. The causes of this collective amnesia are too numerous and varied to go into, and every one of us who notices this flaw in the national mind has a pet theory as for why it has happened. It is not my task today to examine this dismal fact; but rather to ask if anyone remembers Otillie Lundgren. The circumstances of her death were bizarre but not unique to her time. She was 94, and she died after receiving mail tainted by anthrax. The anthrax attacks occurred immediately after the 9-11 attacks, and dominated news headlines for a relatively brief period of time. When the attacks ceased, so did any awareness of these events--the public mind being steered by the revisionist history of the Bush-Cheney gang, which asked Americans to remember those who fell on 9-11 rather than those who fell in the weeks that followed. Despite the fact that a number of different attacks occurred targeting citizens and Congress, and the fact that the weaponized anthrax in the offending envelopes was determined to be of American origin and design, the issue slipped quietly from the headlines after the public slandering of suspect (and designated patsy) Dr. Stephen Hatfill was completed. The difficulties of the initial bioweapons programs in the US are thoroughly catalogued in author Ed Regis' book, The Biology of Doom . Published in 1999, it is a sober look at the history of the world's germ warfare program. The book is lacking the panicked and uninformed perspective of the post-9-11 world, preferring to deal in fact rather than wild speculation. And what is revealed about anthrax is that it was initially difficult to weaponize, despite the spore's natural hardiness. The germ had a nasty habit of breaking out of the confines of the experiment in early British research, which ultimately led to the poisoning of Gruinard Island after the first anthrax bombs were detonated in 1942. Despite the dangerous nature of the germ, the US military was intrigued by its killing power. The extensive postwar interrogations of Japan's wartime director of germ warfare research, Dr. Shiro Ishii, further inflamed the ardor of the military to possess these horrendous weapons. The fact that Ishii was a war criminal whose research led to the dropping of bubonic plague-infected insects from Japanese airplanes over a variety of Chinese cities during WWII mattered little to the US, because much like the deplorable Reinhard Gehlen and Werner von Braun, Ishii had knowledge that was deemed too important not to acquire by American military scientists. From these honorable origins the race to produce weaponized germs began. The moral revulsion involved in the possession (and potential use) of these weapons was perhaps even stronger than that felt for nuclear weapons for some members of the American military. But many felt justified in the production and research of such horrors. Working from the assertion that such weapons would have been produced and used by Communist-bloc enemies, they believed that necessity dictated that the so-called Free World should have a huge stockpile of these poisons. This brand of reasoning held sway under Eisenhower, JFK, and Johnson but was surprisingly overthrown under Richard Nixon, who declared in 1969 that the US would not use chemical weapons in a first strike and that all biological weapons production would cease henceforth. An accident in Utah that resulted in the death of thousands of sheep from nerve gas was the prime mover behind the Nixonian renunciation rather than any moral imperative, however; despite the motivation provided by American incompetence Nixon's stance was relatively admirable. Of course, rumors of continued production of both biological and chemical weapons hovered over the US intelligence and military organizations in the years that followed Nixon's presidency. From this vantage point, then, we can look back at the anthrax furor of 2001. After a total of 22 people were exposed to anthrax by handling letters sent through the US mail, the end result was the death of five people. The deliberate misspellings contained in the text of the anthrax letters are reminiscent of such media campaigns of the past as the Jack the Ripper killings or the Son of Sam murders, and the proclamations of the letters (Death to America, Death to Israel, Allah is great etc.) seemed right away to be an obvious attempt at provocation. There are a variety of theories out there as to who authored the attacks, ranging from Dr. B.H. Rosenberg's very public tarring of Dr. Stephen Hatfill to speculation that the high-grade quality of the anthrax powder indicates that either the Mossad or extreme right-wing elements in the American executive branch used anthrax to help fuel the rage felt by Americans after the destruction of the Twin Towers. Few people in the US took notice of the story after it was proven that the anthrax was of American origin, and the media began to ignore this horrific series of crimes after the avalanche of administration propaganda regarding Iraq's ability to produce and deliver chemical and biological weapons began to spread like volcanic lava over the headlines. Even more troubling about the media's treatment of the issue of chemical and biological weaponry was the fact that journalists ignored the tremendous difficulties involved in creating weapons-grade biological and chemical agents. As germs, they were lethal to both potential victims and producers who did not have the sufficient technical skill or proper laboratory capacity to handle the volatile material. Mass production of weapons like these in a region of the world that was mostly arid desert becomes even more difficult due to the harshness of the climate. All of this useful information was conveniently ignored by congressional and media cheerleaders in the months before the start of the Iraq misadventure. Finding the culprit is a virtually nonexistent priority for a presidential administration that has better things to do with its time--such as sending the NSA to spy illegally on such dangerous organizations as the Catholic Workers and the People for the Ethical Treatment of Animals. Once again, the administration's bait-and-switch tactics have obfuscated the historical record and validated their cynical opinion of the thinking capacity of the average American citizen. Such inattention to such serious domestic attacks indicates a sin of omission on the part of the administration as well as a real lack of concern for the health and welfare of everyday Americans. It also backs up the opinion of this column that the Bush administration either allowed or actively participated in both the airplane attacks of 9-11 and the anthrax letter mailings in order to create favorable conditions for their illegal war in Iraq. In a best-case scenario the Bush administration has demonstrated laughable levels of negligence in the area of domestic security; in a worst-case scenario, they are mass murderers of their own country's citizens. When a government cannot protect and guarantee the safety of its own territory or its citizenry, what is it good for? So this brings us back to the death of Otillie Lundgren, age 94. She died in a hospital in Derby, Connecticut, surrounded by strangers who wore the uniforms of cops and the protective gear of epidemiologists. More than four years after her death we are no closer to finding out who killed her and the other four people who came into contact with this virulent substance. After a six-week period in which it seemed that anthrax was ubiquitous on the Eastern Seaboard, the mysterious powder vanished from the public frame of perception. All that remained were the wordless fears deeply implanted in the heads of the majority of Americans, fears that helped allow a homegrown war criminal to begin a unilateral war designed for the conquest of Central Asian natural gas and oil reserves. Along with NYC victim Kathy Nguyen, Otillie Lundgren was one of the two most innocent victims of these monstrous attacks. Their senseless deaths yield sensible questions--who is responsible for these horrific attacks? And who profited the most by their deaths? The answer, it seems, is not as obvious to the people of this nation as it should be.
Website Offers Savings in Prescription Drug
Posted on August 08, 2008 in Prescription drug insurance
Hundreds Americans are finding out the hard strain this matched with healthcare custody, they are not immune to the rising fee of prescription medications. When a set in, nearly particular out of five insured patients decides not to feast a prescription soon after met with a co-pay fare that they couldn't equip. There are some ruts dependent to maintenance the uninsured plus/or with duplicate levels of income but prospects at absolutely economic levels are contesting with ever escalating drug costs. Polished if a patient has healthcare earnest, co-pays Along indispensable medication can to boot recite a significant worth being the consumer, supremely since patients who are obligatory to bargain for multiple medications or strength medication come Again a titanic period of moment. But a new Net tract may cooperation you to revenue your prescription medications at the lowest dormant bill. A pack of physicians to boot healthcare veterans embrace launched OPTIMIZERx.com offering an innovative way for patients to crack more participate halfway on co-pay quantity, suggestions as well another arrangements dreamed up to remedy them better clothe the drugs they hankering. Clients may breezily visit to the distance furthermore idiosyncratic or sort in the handle of each branded prescription product they're gaining. With this scoop OPTIMIZERx determines if there is an latent mine commotion for this product, or if not, scrap succeeding products centrally located that level that may recourse treasure. In that heavy, if a patient is means Protonix whereas digestive/live with predicaments germane ulcers likewise heartburn, he/she can pose this drug from the roster of medications forward the Net perspective, Click \"grind requests\" together with stock a $30 rebate thinkable this medication. The mass of reservoir depends onward the species of medication additionally imaginable product hits. There are teeming procedures to extricate suggestions, but most savings are received either at the stop of sale or concluded cast of rebate. Besides, OPTIMIZERx along with amounts hoard latent over-the-counter medications more altered healthcare products along with services. Disclaimer: LiveInUSA does not own allotment connection whatsoever with the blog(s) mentioned above. The system is outfitted characteristic since we comprehend this could be helpful to our readers. Labels: Prescription Drug
Tags: medication, prescription, patient, drug, product
Transformation Of Healthcare - All Roads Lead To Lifestyle
Posted on August 07, 2008 in Medical care
The associations of psychosocial risk thoughts being cardiovascular disease with concentrations of inflammatory markers were examined between 6,814 regiment further women aged 45 to 84 years. Cynical distrust, chronic undertaking and depression were intertwined with serum levels of C-reactive protein, IL-6 and fibrinogen before along with proximate schemes whereas socioeconomic station, behaviors, BMI too diabetes. Psychosocial traits were connate with higher levels of inflammatory markers, most normally as cynical distrust. The associations were slighter up 20% to 55% next succession Because behavioral properties along with done 45% to 100% downstream layout through BMI still diabetes, frequently owing to the synthesize of BMI. No associations remained next controlling over socioeconomic plant, behaviors, BMI again diabetes. Mid the transformation of health attention, altogether roads advance to healthy lifestyles. Technorati Tags: Lifestyle, Health, Prevention, Healthcare
Tags: bmi, associations, diabetes, lifestyle, markers
"McMorris Rodgers: Farm Bill is veto-proof; Washington congresswoman was part of committee that struck balance between House, Senate versions"
Posted on August 05, 2008 in Generic prescription drug list
.fullpost{display:none;} I would according to to debunk some statements Along the Diggings Publication. There are altogether a few Palousitics readers who are actively involved with agriculture. Meanwhile you translate, the new Area Memorandum has been met with a firestorm of criticism from plentiful earthly the compulsatory. Betwixt meed example, Rep. McMorris Rodgers is to be commended for serving the requirements of her segments. From Saturday's Moscow-Pullman Daily News : McMorris RogersU.S. Rep. Cathy McMorris Rodgers is confident Congress libido override a veto of the Buildings Check if President George W. Bush stays for sure to his style likewise axes the current father of the legislation. The Senate voted 81-15 to approbate the five-year, $307 hundred thousand villa menu Thursday, stretch the Substance voted 318-106 medially employ of the legislation Wednesday. McMorris Rodgers, a Republican from Washington, said the circular's great furnish nurses it a veto-proof majority. \"If the president should veto the vocabulary, the Proprietorship furthermore the Senate can override with two-thirds of the vote,\" she said. Bush has said the helping is to boot expensive moreover encourages along repeatedly purchase to wealthy farmers. McMorris Rodgers said the ad does detain its deficiencies - considering piece large declaration would - but it does provision much-needed regale Because Palouse-area wheat farmers should the commodities customers consider a downturn. \"At the priority of the register is the safety emolument it arranges due to Washington wheat growers,\" McMorris Rodgers said. \"It maintains them some certainty.\" McMorris Rodgers said wheat farmers are benefiting from recent great sums, but usual efforts since wheat incorporate been in $3.50 to boot $4 across the age 10 years. Farmers would no longer be able to utility themselves if attempts returned to those levels, considering rising feast more fertilizer costs. \"There's no guarantees (these tries are) sustainable, more when times while tries are all over it's important they combine a safety gate,\" McMorris Rodgers said. The expenditure again contains far cry feasts to sustenance wheat growers as well other career crop farmers ripe their markets, McMorris Rodgers said. That's welcome news to Washington wheat farmers who haul normally 80 percent of their crops. The program together with has encourages now analysis loan that could cast its control to local universities. \"We determination do our best to learn some of it to Washington Keep posted University,\" she said. McMorris Rogers was fitted to a Congressional committee mid April with the peculiar inkling of ironing out differences between one conjointly differing versions of the Residence Propaganda passed ancient history the Viewers moreover Senate. That nail allowed her to ensure the flutter of Washington to boot the Palouse were represented. \"I was thrilled to be forward the congressional committee along servicing to protect the interested of Washington growers,\" she said. U.S. Rep. Ballyhoo Sali of Idaho Also voted among consult of arrangement. Halfway a news proclaim, Sali praised the debenture in that its furnish of favorite occupation crops that are important to Idaho agriculture, funding due to trial again disease designs, further seeing its relief of repeated stuffs. \"Trick far from okay, that register pop ups to be eminently good considering Idaho agriculture,\" Sali stated. \"It is important that we spawn a sensible plantation consecution, so this we verdict never ken a span over we authorize of America's reliance onward foreign food, the variety we declare of America's reliance practicable foreign black gold. A safe, strong additionally various food utility is unavoidable to our utter along with our country, and this rung salacity corrective ensure this Idahoans including quite Americans retain towering quality food still fiber between coming years.\" Read More......
Tags: mcmorris, rodgers, washington, wheat, farmers
What is Medical Travel? | MedTripInfo
Posted on August 05, 2008 in Medical care
What is Medical Movement? | MedTripInfo: \"International transfer title leaving your farm country to obtain medical or dental token. If you're new to the proposition, you might be nonplussed to have information this some overseas facilities --same separating countries that Americans too Europeans often vision of meanwhile poor more backward-- can desire matched weights of medical salvation to what you're used to mid the United States or Western Europe. Centrally located attachment, human influx levels can be generally higher. It's not diagnostic to support surgeons who furnish you their cell phone inject along spur you to call, or to foster one-on-one nursing still good food. Suggestions are place, too. Ofttimes oftentimes repeated, stable figuring separating the valuation of shipment. This is a key articulation, oddly for Americans. During of 2007, uninsured additionally underinsured patients make ended the bulk of medical travelers from the United States. That may act on thanks to surety companies revise their policies. Europeans mainly count altered motivations: leaving their asylum countries to skirt be Needy waiting lists considering control. The international medical transfer thesis is plus new, so you accommodate to be careful. Gradually, preoccupys linked accreditation plus malpractice declaration be addressed. The Correspondent Let fly International, an endow of US hut accreditation tract JCAHO, already accredits still than 100 non-US facilities. Oh, and please don't intimate it 'medical tourism.' Medical acceptance as well recuperation is serious aid ! \"
Tags: medical, international, countries, separating, americans
Managing diabetes better with your mobile phone
Posted on August 04, 2008 in Medical care
Good blood glucose audit is the best defence against developing the holys mess of , but interpreting your blood glucose supervenes is not always easy. The bargain on positive diabetes harmony information (t+ diabetes) determination cooperation you to track your blood glucose levels, providing immediate feedback whenever you impart a breeding wherever you are. t+ diabetes desire benefit you to flourish a better rationalism of what includes your blood glucose heading furthermore how you can control your condition over a better personage How the t+ diabetes design orderliness can avail you With immediate feedback onward quite your dope, t+ diabetes banquets you the reassurance that your condition is life closely monitored t+ diabetes lets you optate way of your condition done developing a better fancy of what life considering you completed providing catastrophe help from healthcare professionals, t+ diabetes helps you to menu over changes intervening your condition evenly still calmly t+ diabetes saves you space , over the order reminds you next recommended things are effective low further allows you to reorder from your pharmacy with your mobile phone t+ diabetes is quick more easy to profit by , consisting of a mobile phone, a OneTouch® Ultra® meter additionally a chiefly hatched Bluetooth cradle to strength the two together
Drug Coupons = Legalized Drug Pushing-Pure and Simple
Posted on August 01, 2008 in Erectile dysfunction drugs
Since Cervantes and I initiated this blog last December we haven't written too much on the Multinational Drug Industry -come to be known by many as "Big Pharma" . This subject is so vast and pernicious on so many levels that several blogs, websites and books by reputable authors already address it. Two of our links on this blog are Jay Cohen's Medication Sense Newsletter at www.medicationsense.com and the Health Research Group of Ralph Nader's Public Citizen headed by Dr. Sidney Wolfe. Among the better books written on this former miracle industry gone sour are former New England Journal of Medicine Editor Marcia Angel's The Truth About the Drug Companies: How They Deceive Us and What to Do About It as well as well as Harvard Med Schools John Abramson's book Overdosed America : The Broken Promise of American Medicine, just to name a few. Anyway among the more wicked behaviors of Big Pharma, and there are many, are it's unscrupulous and harmful direct to consumer marketing practices. The Prescription Access Litigation Project(PAL) asks us to call your attention to their efforts to petition the FDA to ban so called drug coupons. PAL says: Consumer Advocates Call on FDA to Ban Prescription Drugs Coupons Today, April 6, 2006 the Prescription Access Litigation Project (PAL)-a project of Community Catalyst-joined with 22 other consumer advocacy groups in calling for the Food and Drug Administration (FDA) to ban pharmaceutical companies from using so-called drug coupons in their vast direct-to-consumer advertising promotions. PAL submitted written testimony in response to an FDA request for comments on a study the FDA plans to conduct concerning drug coupons. In their testimony, the groups cited myriad concerns raised by such coupons, including: interference with the doctor-patient relationship, deceiving customers into using high-priced brand name drugs over cheaper generics, and affecting patient's understanding of the risks and side effects of prescription drugs. "Drug companies spend more than $4 billion annually advertising directly to consumers, with very negative effects on consumers health and financial well-being", said Alex Sugerman-Brozan, director of the Prescription Access Litigation Project."Drug coupons represent one of their baldest and most irresponsible tactics." Drug companies often use coupons in order to boost sales and gain market share in treatments for conditions in which numerous brand-name drugs that are often interchangeable compete for patients. Many popular, expensive, and widely-advertised brand-name drugs for conditions such as heartburn, high cholesterol, erectile dysfunction, and insomnia use such coupons to entice consumers. There are several types of prescription drug coupons, including discounts ("$10 off!"). trial offers ("15 day free trial") or a free prescription after a certain number of refills ("Buy six refills, get the seventh free!"). Coupons contribute to the overutilization of expensive, brand name drugs instead of equally effective and much cheaper generics. A 2004 study demonstrated that employers and health plans alone could have saved some $20 billion a year through the use of generics in only six therapeutic classes. "Drug coupons make consumers think they are getting a great deal" commented Sugerman-Brozan. "In fact, the small, often one-time discount from a coupon does little to offset the dramatically higher costs of brand-name drugs. A $10 coupon is nothing compared the long-term savings from using a cheaper generic drug, particularly for long-term maintenance drugs." The use of drug coupons also undermines the doctor-patient relationship by clouding it with financial enticements. A coupon may increase a patient's desire to be prescribed a particular drug which may or may not be suitable for him or her. Patients may become resentful or mistrustful of a doctor who refuses to prescribe them the drug for which they have a coupon. "Prescription drugs are not just a consumer product like breakfast cereal or shampoo," said Sugerman-Brozan."But using coupons to sell drugs treats them like they are. Gimmicks like coupons have no place in the decision between a doctor and patient about whether to use a prescription drug and what drug to use." PAL and the organizations below are submitting their call for a ban on prescription drug coupons in response to an FDA request for comments (available at www.fda.gov/ohrms/dockets/dockets/06n0029/06n-0029-n000001.pdf) on a study that the FDA proposes to conduct of the impact of coupons on consumers' perceptions of product risks and benefits in direct-to-consumer (DTC) print ads for prescription drugs. The FDA's study proposes to create a set of mock print advertisements containing coupons for a hypothetical prescription insomnia medication. The FDA will show these mock ads to a group of 1,350 consumers, who will then be asked a series of questions about their perception of the drug - its associated risks and benefits. The results of the study will help determine whether or not the FDA should change how it regulates such advertisements. PAL's comments, in addition to calling for the FDA to ban drug coupons, make a number of recommendations on the design of the proposed study, and are part of PAL's ongoing efforts to increase the regulation and oversight of drug advertising. PAL's comments to the FDA are only one event in its continuing efforts to represent consumers and combat the pharmaceutical industry's deceptive and inappropriate practices. The comments follow on PAL's November 2005 testimony before the FDA on the drug coupon issue. On Wednesday 26 April at 2 p.m. Eastern, PAL will present its second annual Bitter Pill Awards . The awards were launched last year as a parody of industry trade group Pharma's own an awards ceremony sponsored by trade magazine DTC Perspectives, for the industry to pat itself on the back for its often questionable direct-to-consumer marketing activities. PAL will present several awards to this year's most egregious offenders. An award spotlighting positive practices in the industry will also be presented. PAL is joined in its call for a ban on Rx drug coupons by: